Reuters logo
BRIEF-Orexo signs asset purchase agreement with Gesynta Pharma for OX-MPI
October 2, 2017 / 6:05 AM / 21 days ago

BRIEF-Orexo signs asset purchase agreement with Gesynta Pharma for OX-MPI

Oct 2 (Reuters) - Orexo

* Orexo signs asset purchase agreement with Gesynta Pharma for OX-MPI

* Under the asset purchase agreement, Gesynta Pharma AB acquires the assets relating to the OX-MPI program and will progress the candidate drug into proof-of-concept clinical trials

* Under the terms of the agreement Orexo will receive a tiered double digit share of the future revenues that Gesynta Pharma AB generates from the OX-MPI project Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below